UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021

Go back to UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
(NYSE: UCB) Delayed: 36.14 --0 (-0%)
Previous Close $36.14    52 Week High
Open $36.14    52 Week Low
Day High $36.14    P/E N/A 
Day Low $36.14    EPS
Volume 953       

UCB Unsponsored ADR (AMEX: UCBJY) Delayed: 128.64 --0 (-0%)
Previous Close $128.64    52 Week High $46.25 
Open $128.64    52 Week Low $32.74 
Day High $128.64    P/E N/A 
Day Low $128.64    EPS $0.00 
Volume 1,193